The Potential Therapeutic Capacity of Inhibiting the Brain Renin–Angiotensin System in the Treatment of Co-Morbid Conditions in Epilepsy

No abstract is available for this paper.

• Publication year

  2019

• Venue

  CNS Drugs

• Publication date

  2019-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40263-019-00678-4PMID 31680223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Losartan fails to suppress epileptiform activity in brain slices from resected tissues of patients with drug resistant epilepsy.

  2019cited by this paper
• Hypertension, seizures, and epilepsy: a review on pathophysiology and management

  2019cited by this paper
• Effect of aliskiren, a direct renin inhibitor, on the protective action of antiepileptic drugs against pentylenetetrazole‐induced clonic seizures in mice

  2018cited by this paper
• Commonalities in epileptogenic processes from different acute brain insults: Do they translate?

  2018cited by this paper
• Strain-dependent Effects of AT1 Receptor Antagonist Losartan on Spatial Memory Performance of Wistar and Spontaneously Hypertensive Rats in Kainate Model of Temporal Epilepsy

  2018cited by this paper
• Neuroinflammation and sympathetic overactivity: Mechanisms and implications in hypertension.

  2018cited by this paper
• Interactions of aliskiren, a direct renin inhibitor, with antiepileptic drugs in the test of maximal electroshock in mice

  2018cited by this paper
• Losartan suppresses the kainate‐induced changes of angiotensin AT1 receptor expression in a model of comorbid hypertension and epilepsy

  2018cited by this paper
• Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats.

  2017cited by this paper
• Telmisartan attenuates diabetes induced depression in rats

  2017cited by this paper
• Protective Effect of Irbesartan an Angiotensin (AT1) Receptor Antagonist in Unpredictable Chronic Mild Stress Induced Depression in Mice

  2016cited by this paper
• Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta‐analysis of risk factors

  2016cited by this paper
• Changes in protein and gene expression of angiotensin II receptors (AT1 and AT2) in aorta of diabetic and hypertensive rats

  2016cited by this paper
• Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy

  2015cited by this paper
• Long-term intracerebroventricular infusion of angiotensin II after kainate-induced status epilepticus: Effects on epileptogenesis, brain damage, and diurnal behavioral changes.

  2015cited by this paper
• Epilepsy associated with Leukoaraiosis mainly affects temporal lobe: a casual or causal relationship?

  2015cited by this paper
• Angiotensin II and its receptor in activated microglia enhanced neuronal loss and cognitive impairment following pilocarpine-induced status epilepticus.

  2015cited by this paper
• Effects of AT1 receptor antagonism on kainate-induced seizures and concomitant changes in hippocampal extracellular noradrenaline, serotonin, and dopamine levels in Wistar-Kyoto and spontaneously hypertensive rats.

  2015cited by this paper
• Status epilepticus, blood-brain barrier disruption, inflammation, and epileptogenesis.

  2015cited by this paper
• Evaluation and comparison of anticonvulsant activity of telmisartan and olmesartan in experimentally induced animal models of epilepsy.

  2014cited by this paper
• Losartan prevents acquired epilepsy via TGF‐β signaling suppression

  2014cited by this paper
• Evaluation and comparison of anticonvulsant activity of telmisartan and olmesartan in experimentally induced animal models of epilepsy.

  2014cited by this paper
• Fear-Potentiated Behaviour Is Modulated by Central Amygdala Angiotensin II AT1 Receptors Stimulation

  2014cited by this paper
• Interactions between angiotensin AT1 receptor antagonists and second‐generation antiepileptic drugs in the test of maximal electroshock

  2014cited by this paper
• Valsartan reverses depressive/anxiety-like behavior and induces hippocampal neurogenesis and expression of BDNF protein in unpredictable chronic mild stress mice.

  2014cited by this paper
• : A practical clinical definition of epilepsy

  2014cited by this paper
• Changes in Hippocampal Volume are Correlated with Cell Loss but Not with Seizure Frequency in Two Chronic Models of Temporal Lobe Epilepsy

  2014cited by this paper
• Receptors of peptides as therapeutic targets in epilepsy research.

  2014cited by this paper
• Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy.

  2014cited by this paper
• Combined treatment with gabapentin and drugs affecting the renin-angiotensin system against electroconvulsions in mice.

  2013cited by this paper
• Neuropeptides in epilepsy.

  2013cited by this paper
• Strain-Dependent Effects of Sub-chronically Infused Losartan Against Kainic Acid-Induced Seizures, Oxidative Stress, and Heat Shock Protein 72 Expression

  2013cited by this paper
• Strain-dependent effects of long-term treatment with melatonin on kainic acid-induced status epilepticus, oxidative stress and the expression of heat shock proteins.

  2013cited by this paper
• The brain renin–angiotensin system: a diversity of functions and implications for CNS diseases

  2012cited by this paper
• The levels of renin-angiotensin related components are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy.

  2012cited by this paper
• Brain Renin–Angiotensin System in Hypertension, Cardiac Hypertrophy, and Heart Failure

  2012cited by this paper
• Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.

  2012cited by this paper
• Candesartan, an Angiotensin II AT1-Receptor Blocker and PPAR-γ Agonist, Reduces Lesion Volume and Improves Motor and Memory Function After Traumatic Brain Injury in Mice

  2012cited by this paper
• Carbamazepine inhibits angiotensin I-converting enzyme, linking it to the pathogenesis of temporal lobe epilepsy

  2012cited by this paper
• Effect of angiotensin II on spatial memory, cerebral blood flow, cholinergic neurotransmission, and brain derived neurotrophic factor in rats

  2012cited by this paper
• Roles of Brain Angiotensin II in Cognitive Function and Dementia

  2012cited by this paper
• Diurnal variations in depression-like behavior of Wistar and spontaneously hypertensive rats in the kainate model of temporal lobe epilepsy.

  2011cited by this paper
• Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

  2011cited by this paper
• The effects of chronic losartan pretreatment on restraint stress-induced changes in motor activity, nociception and pentylenetetrazol generalized seizures in rats

  2011cited by this paper
• Brain renin-angiotensin--a new look at an old system.

  2011cited by this paper
• Cortical and hippocampal EEG effects of neurotransmitter agonists in spontaneously hypertensive vs. kainate-treated rats.

  2011cited by this paper
• Angiotensin AT1 receptor antagonists enhance the anticonvulsant action of valproate in the mouse model of maximal electroshock.

  2010cited by this paper
• Vascular changes in epilepsy: functional consequences and association with network plasticity in pilocarpine-induced experimental epilepsy.

  2010cited by this paper
• Inhibition of the renin-angiotensin system prevents seizures in a rat model of epilepsy.

  2010cited by this paper
• Psychiatric comorbidity and impact on health service utilization in a community sample of patients with epilepsy

  2009cited by this paper
• Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

  2008cited by this paper
• Ang II and Ang IV: Unraveling the Mechanism of Action on Synaptic Plasticity, Memory, and Epilepsy

  2008cited by this paper
• Antidepressant activity of fosinopril, ramipril and losartan, but not of lisinopril in depressive paradigms of albino rats and mice.

  2008cited by this paper
• Involvement of insulin-regulated aminopeptidase in the effects of the renin–angiotensin fragment angiotensin IV: a review

  2008cited by this paper
• The renin‐angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis

  2008cited by this paper
• Seizure activity and changes in hippocampal extracellular glutamate, GABA, dopamine and serotonin.

  2008cited by this paper
• Protective effect of vineatrol against kainic acid induced seizures, oxidative stress and on the expression of heat shock proteins in rats.

  2006cited by this paper
• Insulin resistance and sympathetic overactivity in women.

  2006cited by this paper
• Individual differences in anxiety trait are related to spatial learning abilities and hippocampal expression of mineralocorticoid receptors.

  2006cited by this paper
• Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: possible involvement of noradrenergic mechanism.

  2006cited by this paper
• Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.

  2006cited by this paper
• Abnormalities of the Hippocampus are Similar in Deoxycorticosterone Acetate‐Salt Hypertensive Rats and Spontaneously Hypertensive Rats

  2006cited by this paper
• Angiotensin II: multitasking in the brain

  2006cited by this paper
• Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility?

  2005cited by this paper
• Neuroprotection with Angiotensin Receptor Antagonists

  2005cited by this paper
• Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death.

  2005cited by this paper
• Effects of angiotensin II type 1 receptor blockade on the oxidative stress in spontaneously hypertensive rat tissues.

  2005cited by this paper
• [Qualitative study of hippocampal formation in hypertensive rats with epilepsy].

  2005cited by this paper
• Angiotensin-II behaves as an endogenous pro-inflammatory molecule.

  2005cited by this paper
• Update on the role of the AT2 receptor

  2005cited by this paper
• Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists.

  2005cited by this paper
• A 5‐Month Period of Epilepsy Impairs Spatial Memory, Decreases Anxiety, but Spares Object Recognition in the Lithium‐pilocarpine Model in Adult Rats

  2005cited by this paper
• Angiotensin-II behaves as an endogenous pro-inflammatory molecule.

  2005cited by this paper
• Estudo qualitativo da formação hipocampal de animais hipertensos com epilepsia

  2005cited by this paper
• Concerted action of the renin-angiotensin system, mitochondria, and antioxidant defenses in aging.

  2004cited by this paper
• Angiotensin II Impairs Neurovascular Coupling in Neocortex Through NADPH Oxidase–Derived Radicals

  2004cited by this paper
• The Epidemiology of the Comorbidity of Epilepsy in the General Population

  2004cited by this paper
• ANG II-induced excitation of paraventricular nucleus magnocellular neurons: a role for glutamate interneurons.

  2004cited by this paper
• Hypertension Caused by Angiotensin II Infusion Involves Increased Superoxide Production in the Central Nervous System

  2004cited by this paper
• Indomethacin and cerebrovascular permeability to albumin in acute hypertension and cerebral embolism in the rat

  2004cited by this paper
• Responses to GABA-A receptor blockade in the hypothalamic PVN are attenuated by local AT1 receptor antagonism.

  2003cited by this paper
• Common pathogenic mechanisms between depression and epilepsy: an experimental perspective.

  2003cited by this paper
• Effect of losartan on the blood-brain barrier permeability in diabetic hypertensive rats.

  2003cited by this paper
• Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression.

  2003cited by this paper
• How long does it take for partial epilepsy to become intractable?

  2003cited by this paper
• Angiotensin AT1/AT2 Receptors: Regulation, Signalling and Function

  2003cited by this paper
• Age‐Related Decline in Spatial Learning and Memory: Attenuation by Captopril

  2003cited by this paper
• Valproate: a practical review of its uses in neurological and psychiatric disorders

  2002cited by this paper
• Apoptosis: a guide for the perplexed.

  2002cited by this paper
• Effects of losartan on the blood-brain barrier permeability in long-term nitric oxide blockade-induced hypertensive rats.

  2002cited by this paper
• Losartan Reduces Central and Peripheral Sympathetic Nerve Activity in a Rat Model of Neurogenic Hypertension

  2002cited by this paper
• Seizures, Hypertension, and Posterior Leukoencephalopathy

  2002cited by this paper
• The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data.

  2001cited by this paper
• When do epileptic seizures really begin?

  2001cited by this paper
• Seizures induce phase shifts of rat circadian rhythms.

  2001cited by this paper
• Epileptic Seizures May Begin Clinical Study Hours in Advance of Clinical Onset: A Report of Five Patients

  2001cited by this paper
• Life-threatening adverse events of antiepileptic drugs.

  2001cited by this paper
• Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): interaction with adenosine A(1) receptors.

  2001cited by this paper
• Various effects of angiotensin II on amygdaloid neuronal activity in normotensive control and hypertensive transgenic [TGR(mREN‐2)27] rats

  2000cited by this paper
• Long-term theophylline treatment changes the effects of angiotensin II and adenosinergic agents on the seizure threshold.

  2000cited by this paper

• Pyridostigmine-Induced Status Epilepticus Rat Model Was Resistant to Increasing Doses of Ramipril: The Latter Triggered Epileptogenesis, Arrhythmia, and Cardiac Ischemia in a Dose-Dependent Manner

  2025cites this paper
• Candesartan restores blood-brain barrier dysfunction, mitigates aberrant gene expression, and extends lifespan in a knockin mouse model of epileptogenesis.

  2024cites this paper
• The Development of Epilepsy Following CNS Viral Infections: Mechanisms

  2024cites this paper
• The Relationship among SARS-CoV-2, Vaccine Spike Protein, Renin- Angiotensin System, and Epilepsy.

  2024cites this paper
• Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With a Reduced Risk of Poststroke Epilepsy in Patients With Ischemic Stroke

  2024cites this paper
• Risk Factors for Seizures After Titanium Cranioplasty: Five-Year Experience from A Single Institution.

  2023cites this paper
• Angiotensin‐converting enzymes as druggable features of psychiatric and neurodegenerative disorders

  2023cites this paper
• The role of angiotensin receptor blockers in treating epilepsy: a review

  2023influential citation
• Captopril alleviates epilepsy and cognitive impairment by attenuation of C3-mediated inflammation and synaptic phagocytosis

  2022cites this paper
• Recent Advances in the Endogenous Brain Renin-Angiotensin System and Drugs Acting on It

  2021cites this paper
• Brain angiotensin system: a new promise in the management of epilepsy?

  2021cites this paper
• A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View

  2020cites this paper
• Plasma angiotensin II levels in women with severe preeclampsia under magnesium sulfate regimen.

  2020cites this paper